MIAMI, FLORIDA, USA, June 20, 2024 /EINPresswire.com/ -- Mel-Mont Medical, Inc., an innovative leader in precision HPV mRNA extended genotyping and sample collection ...
MedPage Today on MSN
Short-Interval HPV Retesting Shows Triage Promise for Cervical Cancer Screening
Persistent HPV infection is the principal cause of cervical cancer. HPV-based screening is effective but has limited ...
The American Society for Colposcopy and Cervical Pathology (ASCCP) has issued new guidelines reflecting the importance of extended genotyping in HPV testing to support an enhanced standard of patient ...
Pap tests and HPV testing are a vital part of women's health care, but many people dread the invasive examination every three years. For some women, particularly sexual violence survivors, getting ...
Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
Discover the latest innovations in cervical cancer prevention and molecular diagnostics. This event will showcase cutting-edge advancements in integrated molecular automation and innovative assay ...
Cervical cancer remains one of the most preventable yet deadly cancers for women worldwide, with vast disparities between high-income nations and low- and middle-income countries.
The U.S. Human Papilloma Virus (HPV) testing market is poised for significant growth, projected to reach $1.01 billion by ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Though vaginal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results